The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Co-expressing pattern of multiple biomakers and dynamic change of Claudin18.2 expression after systemic chemotherapy in advanced gastric cancer.
 
Sun Young Rha
Consulting or Advisory Role - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Daiichi Sankyo; Eisai; indivumed; LG Chem; MSD Oncology; Ono Pharmaceutical; Toray Industries
Speakers' Bureau - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; BMS/Ono; Daiichi Sankyo/UCB Japan; Eisai; MSD Oncology
Research Funding - Amgen (Inst); ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daichii Sankyo; Eisai; Indivumed; Lilly; MSD Oncology; Roche/Genentech; Sillajen; Zymeworks
 
Woo Sun Kwon
No Relationships to Disclose
 
Choong-kun Lee
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Roche; SERVIER
Speakers' Bureau - Boryung Pharmaceuticals; Celgene/Bristol-Myers Squibb; Handok; Novartis; Sanofi
Research Funding - Boryung Pharmaceuticals (Inst); GC Biopharma (Inst); Lunit (Inst); Ono Pharmaceutical (Inst)
 
Minkyu Jung
Employment - Ensol Biosciences (I)
Stock and Other Ownership Interests - Ensol Biosciences; Ensol Biosciences (I)
Honoraria - Celltrion; Lilly
 
Su-Jin Shin
No Relationships to Disclose
 
Heejin Kim
No Relationships to Disclose
 
Sejung Park
No Relationships to Disclose
 
Ju Hee Yoo
No Relationships to Disclose
 
Hyunki Kim
No Relationships to Disclose